CG
IGC icon

Cutler Group’s IGC Pharma IGC Stock Holding History

Cutler Group’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-796
Closed – – 5176
2022
Q2 		$0 Hold
796
– – ﹤0.01% 5271
2022
Q1 		$0 Sell
796
-1,604
-67% -$1.56K ﹤0.01% 5636
2021
Q4 		$2K Sell
2,400
-1,700
-41% -$2.28K ﹤0.01% 4747
2021
Q3 		$6K Sell
4,100
-1,757
-30% -$2.84K ﹤0.01% 4329
2021
Q2 		$9K Sell
5,857
-4,500
-43% -$6.87K ﹤0.01% 3977
2021
Q1 		$18K Buy
10,357
+4,857
+88% +$8.82K ﹤0.01% 3294
2020
Q4 		$8K Buy
5,500
+400
+8% +$591 ﹤0.01% 3343
2020
Q3 		$5K Buy
5,100
+3,800
+292% +$3.86K ﹤0.01% 3499
2020
Q2 		$0 Hold
1,300
– – ﹤0.01% 4600
2020
Q1 		$0 Hold
1,300
– – ﹤0.01% 4301
2019
Q4 		$0 Buy
1,300
+1,000
+333% +$818 ﹤0.01% 4256
2019
Q3 		$0 Hold
300
– – ﹤0.01% 4344
2019
Q2 		$0 Hold
300
– – ﹤0.01% 4494
2019
Q1 		$0 Buy
+300
New +$682 ﹤0.01% 4358

Other funds holding IGC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Cutler Group's IGC Position: Q3 2022 in Review

Cutler Group sold out of IGC Pharma (IGC) in Q3 2022, closing a stake of 796 shares.

Cutler Group first reported a position in IGC in Q1 2019 and held it in 14 quarters. The position peaked at $18K in Q1 2021. 26 funds tracked by Wall St. Rank hold IGC as of Q3 2022.

  • Cutler Group reported no remaining IGC Pharma position as of Q3 2022 after selling out during the quarter.
  • Cutler Group sold 796 IGC Pharma shares in Q3 2022.
  • Cutler Group first reported a position in IGC Pharma in Q1 2019 and held it in 14 quarters.
  • Cutler Group's IGC Pharma position peaked at $18K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held IGC Pharma as of Q3 2022.

Based on Cutler Group's 13F filing for Q3 2022, filed 25 Oct 2022.